Top compounds associated with response to FZD1


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.037 0.4
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.4
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.035 0.4
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.031 0.4
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.4
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.051 0.4
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC -0.037 0.4
mRNA LY317615 GDSC1000 pan-cancer AAC -0.033 0.4
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.04 0.4
Download CSV